Bettapharma | Briefing, News, Analysis, Research, Data

Bettapharma

Bettapharma mainly providing customers with products such as Ectinib hydrochlorid

Beda Pharmaceuticals is an innovative drug developer in the fields of malignancy, ophthalmology, autoimmune diseases and diabetes, mainly providing customers with products such as Ectinib hydrochloride (Kemena), new antineoplastic drug CM082 and other products, including six national Class I and Class II new drugs, and 14 national Class III and Class IV new drugs in the pipeline.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 1, 2003

HQ location

Zhejiang, China

Legal name

Betta Pharmaceuticals Co., Ltd.

Website

http://www.bettapharma.com/

betta0107@bettapharma.com

Employees

501-1000

All
News
Analysis
Research

Briefing May 20, 2022 03:55 PM · Technology | Consumer Staples | Healthcare

Cbcirc: focus on investigating and dealing with the illegal transfer of interests through credit, bonds, discount and other means

Briefing Feb 09, 2022 03:50 PM · Technology | Consumer Staples | Healthcare

Tonghua Dongbao: Notice of acceptance of the production declaration of engeliejing tablets

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Jan 24, 2022 07:29 PM · Technology | Healthcare | Financials

Jingke energy: it will be listed on the scientific innovation board on January 26

Briefing Jan 14, 2022 05:29 PM · Technology | Healthcare | Real Estate

Dirui medical: recently obtained 11 medical device registration certificates

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Financials, Technology

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Nov 29, 2021 07:59 PM · Healthcare

Boten Co., Ltd.: direnavir API has passed who PQ certification

Briefing Sep 06, 2021 09:05 PM · Healthcare | Real Estate

Beida pharmaceutical: 4510000 shares pledged by Kaiming investment

Briefing Aug 31, 2021 08:59 PM

TECO shares: obtained an invention patent certificate

Briefing Aug 26, 2021 04:53 PM · Consumer Staples | Healthcare | Financials

Renrenle: it lost 365 million yuan in the first half of the year, closed 19 supermarket stores and opened 3 new ones

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Aug 06, 2021 06:35 PM · Healthcare | Financials

Zhongheng design: at the expiration of the reduction period, some executives have reduced 35000 shares in total

Briefing Jul 15, 2021 03:47 PM · Consumer Staples | Healthcare | Automotive

Dwell: shareholders Yang Jianmin and Lu Weidong plan to reduce their total shares by no more than 7.5%

Briefing Jul 13, 2021 04:01 PM · Technology | Healthcare

Beida pharmaceutical: application for registration of first-line treatment indications of ensatinib hydrochloride accepted

Healthcare

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

May 15, 2024 03:21 PM

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Briefing Jul 07, 2021 03:24 PM · Healthcare

The first bank of China fund to release its second Quarterly Report

Briefing Jun 17, 2021 06:10 PM · Technology | Healthcare

Yonghe medical group submits listing application to HKEx

Briefing Jun 10, 2021 06:50 PM · Consumer Staples | Healthcare | Financials

Beida pharmaceutical: clinical trial of batirizumab injection in the treatment of cervical cancer approved

Briefing Dec 11, 2020 08:17 PM · Healthcare

Beida pharmaceutical: the three shareholders intend to reduce the shares of the company no more than 2.31%

EqualOcean Analysis